Vestibular Reflexes and Positional Manoeuvres
JNNP 74:289-293, Bronstein,A.M., 2003
[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003
Neuropsychological and Quality of Life Outcomes 12 Months After Unilateral Thalamic Stimulation for Essential Tremor
JNNP 74:305-311, Fields,J.A.,et al, 2003
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
How Valid is the Clinical Diagnosis of Parkinson's Disease in the Community?
JNNP 73:529-534, Scharg,A.,et al, 2002
Effect on Mood of Subthalamic DBS for Parkinson's Disease
Neurol 59:1427-1429, Berney,A.,et al, 2002
Mania Following Deep Brain Stimulation for Parkinson's Disease
Neurol 59:1421-1424, Kulisevsky,J.,et al, 2002
Incidental Findings on Pediatric MR Images of the Brain
AJNR 23:1674-1677, Kim,B.S.,et al, 2002
Headache Diagnosis in Patients with Treated Idiopathic Intracranial Hypertension
Neurol 58:1551-1553, Friedman,D.I. &Rausch,E.A., 2002
Diagnostic Criteria for Idiopathic Intracranial Hypertension
Neurol 59:1492-1495, Friedman,D.I. &Jacobson,D.M., 2002
Incidence and Outcome of Mild Cognitive Impairment in a Population-Based Prospective Cohort
Neurol 59;1594-1599, Larrieu,S.,et al, 2002
Driving Safety in Parkinson's Disease
Neurol 59:1787-1788, Zesiewicz,T.A.,et al, 2002
Isolated Hand Palsy Due to Cortical Infarction: Localization of the Motor Hand Area
Neurol 58:1412-1414, Takahashi,N.,et al, 2002
Treatment Interventions for Parkinson's Disease: An Evidence Based Assessment
Lancet 359:1589-1598, Rascol,O.,et al, 2002
Impact of Sustained Deprenyl (Selegiline) in Levodopa-Treated Parkinson's Disease: A Randomized Placebo-Controlled Extension of the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism Trial
Ann Nuerol 51:604-612, Shoulson,I.,et al, 2002
Cholinergic Vesicular Transporters in Progressive Supranuclesar Palsy
Neurol 58:1013-1018,997, Suzuki,M.,et al, 2002
Botulinum Toxin for Cricopharyngeal Dysfunction in Parkinson's Disease
NEJM 346:1174-1175, Restivo,D.A.,et al, 2002
Subthalamic DBS Replaces Levodopa in Parkinson's Disease
Neurol 58:396-401, Vingerhoets,F.J.G.,et al, 2002
Coital Headaches Induced by Amiodarone
Neurol 58:501-502, Biran,I. &Steiner,I., 2002
Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease
JAMA 287:455-463,509, Hobson,D.E.,et al, 2002
Practice Parameter: Initiation of Treatment for Parkinson's Disease: An Evidence-based Review
Neurol 58:11-17, Miyasaki,J.M.,et al, 2002
Cerebral Vasoconstriction and Stroke After Use of Serotonergic Drugs
Neurol 58:130-133, Singhal,A.B.,et al, 2002
Diffusion-weighted MRI Differentiates the Parkinson Variant of Multiple System Atrophy from PD
Neurol 58:575-580, Schocke,M.F.H.,et al, 2002
Positional Down Beating Nystagmus in 50 Patients: Cerebellar Disorders and Possible Anterior Semicircular Canalithiasis
JNNP 72:366-372, Bertholon,P.,et al, 2002
Functional Deficits in Patients with Mild Cognitive Impairment
Neurol 58:758-764, Tabert,M.H.,et al, 2002
Donepezil for Cognitive Impairment in Parkinson's Disease: A Randomised Controlled Study
JNNP 72:708-712, Aarsland,D.,et al, 2002
Incidence and Prediction of Falls in Parkinson's Disease: A Prospecitve Multidisciplinary Study
JNNP 72:721-725, Wood,B.H.,et al, 2002
Diffuse Metabolic Abnormalities in Reversible Posterior Leukoencephalopathy Syndrome
AJNR 23:833-837, Eichler,F.S.,et al, 2002
Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002
Posterior Reversible Encephalopathy Syndrome: Prognostic Utility of Quantitative Diffusion-Weighted MR Images
AJNR 23:1038-1048, Covarrubias,D.J.,et al, 2002
Nonmotor Fluctuations in Parkinson's Disease
Neurol 59:408-413, Witjas,T.,et al, 2002
Natural History of Mild Cognitive Impairment in Older Persons
Neurol 59:198-205, Bennett,D.A.,et al, 2002
Intravascular Lymphomatosis Presenting as Posterior Leukoencephalopathy
Arch Neurol 59:640-641, Moussouttas,M., 2002
A Double-blind Placebo-controlled Trial of Topiramate Treatment for Essential Tremor
Neurol 59:132-134, Connor,G.S., 2002
A Meta-Analysis of Coffee Drinking, Cigarette Smoking, and the Risk of Parkinson's Disease
Ann Neurol 52:276-284,261, Hernan,M.A.,et al, 2002
Clinicopath Conf, Neuronal Ceroid Lipofuscinosis, Late-Onset Infantile Subtype
NEJM 347:672-680, Case 27-2002, 2002
Intakes of Vitamins E and C, Carotenoids, Vitamin Supplements, and PD Risk
Neurol 59:1161-1169, Zhang,S.M.,et al, 2002
T2-weighted MRI Differentiates Multiple System Atrophy from Parkinson's Disease
Neurol 59;1265-1267, Kraft,E.,et al, 2002
Familial Dementia With Lewy Bodies
Arch Neurol 59:1622-1630, Tsuang,D.W.,et al, 2002
Mitochondrial Therapy for Parkinson Disease
Arch Neurol 59:1523, Rosenberg,R.N., 2002
Potentially Reversible Conditions in 1000 Consecutive Memory Clinic Patients
JNNP 73:390-394, Hejl,A.,et al, 2002
Hemolytic Anemia Presenting as Idiopathic Intracranial Hypertension
Neurol 59:960-961, Taylor,J.P.,et al, 2002
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
JAMA 288:1475-1483, Lyketsos,C.G.,et al, 2002
Fragile X Premutation Carriers: Characteristic MR Imaging Findings of Adult Male Patients with Progressive Cerebellar and Cognitive Dysfunction.
AJNR 23:1757-1766, Brunberg,J.A.,et al, 2002
Mild Cognitive Impairment in Older People
Lancet 360:1963-1965, Burns,A., &Zaudig,M., 2002
Bilateral Subthalamic Nucleus Stimulation Improves Health-Related Quality of Life in PD
Neurol 59:1976-1978, Lagrange,E.,et al, 2002
Holmes Tremor Following Midbrain Toxoplasma Abscess: Clinical Features and Treatment of a Case
Park Rel Dis 8:177-180, Pezzini, A.,et al, 2002
Gemcitabine-Associated Posterior Reversible Encephalopathy Syndrome: MR Imaging and MR Spectroscopy Findings
Magnetic Resonance Imaging 19:129-132, Russell,M.T,et al, 2001
Cisternal Cysticercosis: A Diagnostic Problem--A Short Report
Neurol India 49:206-208, Bannur,U. &Rajshekhar V., 2001
Cerebral Amyloid Angiopathy Presenting as Nonhemorrhagic Diffuse Encephalopathy: Neuropathologic and Neuroradiologic Manifestations in One Case
AJNR 22:1072-1076, Caulo,M.,et al, 2001